Pharmacologic Management of Painful Bladder Syndrome/Interstitial Cystitis
Open Access
- 8 October 2007
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 167 (18) , 1922-1929
Abstract
Painful bladder syndrome/interstitial cystitis (PBS/IC) is a poorly defined clinical condition characterized by 3 key symptoms: pelvic pain, urinary urgency, and urinary frequency.1 These symptoms significantly overlap with those of other common conditions and are not associated with any known pathognomonic tissue, serum, or urinary changes. The diagnosis of PBS/IC is therefore primarily one of exclusion.2 Further complicating diagnosis is the lack of a standard definition. In 1915, for example, Hunner3 described a form of bladder ulceration later designated classic IC. In 1978, Messing and Stamey4 proposed that glomerulations apparent with bladder distension were diagnostic of IC in the absence of Hunner ulcerations (ie, nonulcerative IC). Most recently, in 1987, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) attempted to unify these contrasting approaches by developing a list of criteria to define IC.5 The NIDDK criteria, however, miss an estimated 60% of patients and, because of the criteria's restrictiveness, are currently recommended for research use only.6 Moreover, Waxman et al7 and others8,9 have called into question the specificity of the criteria by finding that 75% of healthy women show glomerulations even in the absence of symptoms. The term PBS is now often used to describe the broader spectrum of cases that meet a more inclusive, symptom-based definition, without the typical cystoscopic and histologic features that have traditionally been used to distinguish IC.2,10Keywords
This publication has 48 references indexed in Scilit:
- PREVALENCE OF CLINICALLY CONFIRMED INTERSTITIAL CYSTITIS IN WOMEN: A POPULATION BASED STUDY IN FINLANDJournal of Urology, 2005
- INTRAVESICAL RESINIFERATOXIN FOR THE TREATMENT OF INTERSTITIAL CYSTITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIALJournal of Urology, 2005
- A RANDOMIZED CONTROLLED TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TREATMENT REFRACTORY INTERSTITIAL CYSTITISJournal of Urology, 2005
- PREVALENCE AND INCIDENCE OF INTERSTITIAL CYSTITIS IN A MANAGED CARE POPULATIONJournal of Urology, 2005
- Overactive bladder and painful bladder syndrome: There need not be confusionNeurourology and Urodynamics, 2004
- A PROSPECTIVE, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND STUDY OF AMITRIPTYLINE FOR THE TREATMENT OF INTERSTITIAL CYSTITISJournal of Urology, 2004
- Incidence of physician‐diagnosed interstitial cystitis in Olmsted County: a community‐based studyBJU International, 2003
- INTRAVESICAL RESINIFERATOXIN FOR THE TREATMENT OF HYPERSENSITIVE DISORDER: A RANDOMIZED PLACEBO CONTROLLED STUDYJournal of Urology, 2000
- A PROSPECTIVE STUDY OF INTERSTITIAL CYSTITIS: RESULTS OF LONGITUDINAL FOLLOWUP OF THE INTERSTITIAL CYSTITIS DATA BASE COHORTJournal of Urology, 2000
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986